Get the Stockscreener App
1.23
5.38%
-0.07
Pre-market:
1.23
Tela Bio Inc stock is traded at $1.23, with a volume of 365.09K.
It is down -5.38% in the last 24 hours and down -17.45% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.30
Open:
$1.32
24h Volume:
365.09K
Relative Volume:
3.72
Market Cap:
$48.73M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-0.7365
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
-16.89%
1M Performance:
-17.45%
6M Performance:
+26.80%
1Y Performance:
-56.23%
1-Day Range:
$1.13
$1.334
1-Week Range:
$1.13
$1.505
52-Week Range:
$0.8645
$3.26
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.23 | 51.50M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
Applying Elliott Wave Theory to TELA Bio Inc.July 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Will TELA Bio Inc. stock return to pre crisis levels2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
What moving averages say about TELA Bio Inc.2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
How buybacks impact TELA Bio Inc. stock value2025 Key Lessons & Free Verified High Yield Trade Plans - newser.com
Is TELA Bio Inc. stock ready for a breakoutIndex Update & Stock Portfolio Risk Management - newser.com
Can TELA Bio Inc. stock deliver surprise earnings beatDollar Strength & Pattern Based Trade Signal System - newser.com
Why TELA Bio Inc. is moving todayTrade Risk Report & Free Long-Term Investment Growth Plans - newser.com
Why hedge funds are buying TELA Bio Inc. stockQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com
How Resonance Specialties Limited’s Balance Sheet Supports Long‑Term GrowthTechnical Pattern Recognition & Download Your Free Wealth Map PDF - earlytimes.in
TELA Bio (TELA) to Release Quarterly Earnings on Thursday - MarketBeat
What risks investors should watch in TELA Bio Inc. stock2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Does TELA Bio Inc. show high probability of reboundWall Street Watch & Low Drawdown Trading Strategies - newser.com
Measuring TELA Bio Inc.’s beta against major indicesOil Prices & Free Technical Confirmation Trade Alerts - newser.com
What to do if you’re stuck in TELA Bio Inc.Portfolio Return Summary & Low Risk Investment Opportunities - newser.com
Tela Bio’s OviTex PRS Study: A New Frontier in Breast Reconstruction - TipRanks
Why TELA Bio Inc. stock could rally in 2025Entry Point & Technical Pattern Based Signals - fcp.pa.gov.br
Tela Bio’s OviTex Study: A Potential Game-Changer in Hernia Repair - TipRanks
Tela Bio’s OviTex Study: A Potential Game-Changer for Hiatal Hernia Treatment - TipRanks
Tela Bio’s OviTex PRS Study: A Potential Game-Changer in Breast Reconstruction - TipRanks
Will TELA Bio Inc. stock benefit from green energy trends2025 Support & Resistance & AI Powered Market Trend Analysis - Fundação Cultural do Pará
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):